Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Melphalan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for melphalan and what is the scope of melphalan patent protection?

Melphalan
is the generic ingredient in four branded drugs marketed by Alvogen Malta, Apotex Inc, West-ward Pharms Int, Actavis Llc, Spectrum Pharms, Mylan Institutional, Par Sterile Products, and Sagent Pharms, and is included in ten NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for melphalan. Two suppliers are listed for this compound.

Summary for Generic Name: melphalan

Tradenames:4
Patents:4
Applicants:8
NDAs:10
Drug Master File Entries: see list12
Suppliers / Packagers: see list2
Bulk Api Vendors: see list42
Clinical Trials: see list338
Patent Applications: see list9,878
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:melphalan at DailyMed

Pharmacology for Ingredient: melphalan

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION204773-001Aug 22, 2016APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION090303-001Oct 28, 2010APRXNoNo► Subscribe► Subscribe
Spectrum Pharms
EVOMELA
melphalan hydrochloride
POWDER;IV (INFUSION)207155-001Mar 10, 2016RXNoNo9,200,088► SubscribeY ► Subscribe
Apotex Inc
ALKERAN
melphalan
TABLET;ORAL014691-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Spectrum Pharms
EVOMELA
melphalan hydrochloride
POWDER;IV (INFUSION)207155-001Mar 10, 2016RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot